These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22818111)
21. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns. Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372 [TBL] [Abstract][Full Text] [Related]
22. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471 [TBL] [Abstract][Full Text] [Related]
23. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006 [TBL] [Abstract][Full Text] [Related]
24. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region. Laupland KB; Parkins MD; Ross T; Pitout JD Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132 [TBL] [Abstract][Full Text] [Related]
25. Nephrotoxicity associated with intravenous colistin in critically ill patients. Doshi NM; Mount KL; Murphy CV Pharmacotherapy; 2011 Dec; 31(12):1257-64. PubMed ID: 22122186 [TBL] [Abstract][Full Text] [Related]
26. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii. Ozbek B; Sentürk A Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399 [TBL] [Abstract][Full Text] [Related]
27. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [TBL] [Abstract][Full Text] [Related]
30. Epidemiological study of Enterobacteriaceae resistance to colistin in Sfax (Tunisia). Mezghani Maalej S; Rekik Meziou M; Mahjoubi F; Hammami A Med Mal Infect; 2012 Jun; 42(6):256-63. PubMed ID: 22633474 [TBL] [Abstract][Full Text] [Related]
31. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570 [TBL] [Abstract][Full Text] [Related]
32. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000 [TBL] [Abstract][Full Text] [Related]
33. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [TBL] [Abstract][Full Text] [Related]
35. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [TBL] [Abstract][Full Text] [Related]
36. Colistin in the treatment of life-threatening infections. Pavleas J; Skiada A; Daikos GL; Rigas K; Mega A; Archondoulis N; Vernikos P; Salatas K; Thomopoulos G Int J Antimicrob Agents; 2006 Oct; 28(4):374-6. PubMed ID: 16963234 [No Abstract] [Full Text] [Related]
37. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of Providencia Strains among Patients with Diarrhea and in Retail Meats in Thailand. Shima A; Hinenoya A; Samosornsuk W; Samosornsuk S; Mungkornkaew N; Yamasaki S Jpn J Infect Dis; 2016 Jul; 69(4):323-5. PubMed ID: 26370430 [TBL] [Abstract][Full Text] [Related]
40. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections. Huang J; Tang YQ; Sun JY Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]